Get the Stockscreener App
86.44
0.17%
0.15
After Hours:
86.70
0.26
+0.30%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $86.44, with a volume of 28.59M.
It is up +0.17% in the last 24 hours and down -6.08% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$86.29
Open:
$85.85
24h Volume:
28.59M
Relative Volume:
3.21
Market Cap:
$110.57B
Revenue:
$36.36B
Net Income/Loss:
$4.84B
P/E Ratio:
23.20
EPS:
3.7261
Net Cash Flow:
$5.43B
1W Performance:
-2.34%
1M Performance:
-6.08%
6M Performance:
+0.44%
1Y Performance:
-8.83%
1-Day Range:
$85.22
$86.84
1-Week Range:
$85.22
$89.53
52-Week Range:
$73.31
$106.33
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
86.44 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
ABT
Abbott Laboratories
|
96.69 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
272.96 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.23 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.19 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Resumed | Barclays | Overweight |
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
AMA approves permanent CPT codes for Medtronic's devices treating urinary incontinence and hypertension. - Pluang
Medtronic receives Category I CPT code approvals for two devices - Investing.com India
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems - Medtronic
Medtronic options flow dominated by large December put spread - Investing.com
Medtronic Sees Unusually High Options Volume (NYSE:MDT) - MarketBeat
Medtronic stock after-hours at EUR 76.62: plus 0.05 percent versus prior close - AD HOC NEWS
Medtronic drug-coated balloon gets FDA breakthrough status - MedTech Dive
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report? - Yahoo Finance
Medtronic reveals cardiac mapping and ablation software clearances - Yahoo Finance
Medtronic Lands FDA Breakthrough Tag and Dual Cardiac Clearances as MiniMed Exchange Offer Looms - AD HOC NEWS
History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade. - The Motley Fool
Medtronic raises fiscal 2027 outlook for Medtronic stock - AD HOC NEWS
Medtronic Reveals Regulatory Milestones for Software Used With Cardiac Ablation Platforms - marketscreener.com
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects - Zacks Investment Research
Medtronic Named to Fortune 2026 'Change the World' List for Touch Surgery(TM) Ecosystem and Healthy Neighbor - ACCESS Newswire
Medtronic gains regulatory clearances for cardiac software By Investing.com - Investing.com Canada
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software - PR Newswire
Medtronic's (MDT) Buy Rating Reaffirmed at TD Cowen - MarketBeat
Medtronic (MDT) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Form 425 Medtronic plc Filed by: Medtronic plc - StreetInsider
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
[425] Medtronic plc Business Combination Communication - Stock Titan
Medtronic stock at USD 88.29 on September 28, 2026 - AD HOC NEWS
Medtronic plc stock at USD 88.64 on September 25, 2026 - AD HOC NEWS
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income? - Yahoo Finance
Pfizer vs. Medtronic: Which Healthcare Turnaround is More Convincing? - Yahoo Finance
Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets? - Insider Monkey
Medtronic Couples Bedside Ultrasound Push With Robotics Bet as MiniMed Split Nears Finish Line - AD HOC NEWS
Medtronic Extends 49-Year Dividend Streak as Stealth AXiS Debuts in European Operating Rooms - AD HOC NEWS
Medtronic Marks 49 Straight Years of Dividend Growth While MiniMed Spinoff Takes Shape - AD HOC NEWS
[425] Medtronic plc Business Combination Communication | MDT SEC FilingForm 425 - Stock Titan
Medtronic PLC's Dividend Analysis - GuruFocus
Medtronic stock trades at USD 88.51 after Q1 growth - AD HOC NEWS
Medtronic stock heads into the open after a 0.88 percent drop - AD HOC NEWS
Medtronic Lifts Guidance as FDA Clears Robot Instrument and MiniMed Spinoff Advances - AD HOC NEWS
Could Medtronic (MDT)’s $700 Million Robotics Bet Unlock its Next Growth Engine? - Yahoo Finance
Medtronic stock falls 1.62 percent after raised FY27 guidance - AD HOC NEWS
Medtronic PLC $MDT Shares Sold by Envestnet Asset Management Inc. - MarketBeat
Medtronic stock heads into the open after a 1.62 percent drop - AD HOC NEWS
Medtronic PLC $MDT Shares Sold by QRG Capital Management Inc. - MarketBeat
Here's Why Medtronic (MDT) Fell More Than Broader Market - Yahoo Finance
Medtronic stock closes lower at the close - AD HOC NEWS
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
Medtronic: Buy The 3% Yield And Strong Free Cash Flow Growth (NYSE:MDT) - Seeking Alpha
Medtronic (MDT): Q1 Beat Sparks Target Hikes, but Wall Street Splits on Re-Rating Case - Yahoo Finance
Medtronic plc (MDT) Options ChainYahoo Finance - Yahoo! Finance Canada
Medtronic: The Turnaround Is No Longer Quiet (NYSE:MDT) - Seeking Alpha
Medtronic stock holds near USD 91 as margins draw attention - AD HOC NEWS
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now - Yahoo Finance UK
Medtronic plc (MDT) latest stock news and headlines - Yahoo Finance Singapore
Andra AP fonden Decreases Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):